ANSBERT GADICKE Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANSBERT GADICKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of ANSBERT GADICKE for July 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31 2020 | ALVR | Allovir, Inc. | GADICKE ANSBERT | Director | Option Exercise | A | 17.00 | 22,500 | 382,500 | 22,500 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 2,600,628 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 29,440 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 79,281 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 1,491,666 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 81,295 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 157,529 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 2,361,805 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 4,211,330 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 47,674 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 128,384 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 2,415,530 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 131,645 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 255,094 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | C | 0.00 | 3,824,591 | 0 | 0 | |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | P | 19.00 | 160,000 | 3,040,000 | 2,355,557 | 2.2 M to 2.4 M (+7.29 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | P | 19.00 | 1,121 | 21,299 | 25,974 | 24.9 K to 26 K (+4.51 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | P | 19.00 | 3,020 | 57,380 | 69,951 | 66.9 K to 70 K (+4.51 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | P | 19.00 | 56,814 | 1,079,466 | 1,316,139 | 1.3 M to 1.3 M (+4.51 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | P | 19.00 | 3,096 | 58,824 | 71,727 | 68.6 K to 71.7 K (+4.51 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | P | 19.00 | 5,994 | 113,886 | 138,985 | 133 K to 139 K (+4.51 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | P | 19.00 | 89,955 | 1,709,145 | 2,083,887 | 2 M to 2.1 M (+4.51 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 797,983 | 0 | 2,195,557 | 1.4 M to 2.2 M (+57.10 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 9,033 | 0 | 24,853 | 15.8 K to 24.9 K (+57.10 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 24,326 | 0 | 66,931 | 42.6 K to 66.9 K (+57.10 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 457,706 | 0 | 1,259,325 | 801.6 K to 1.3 M (+57.10 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 24,944 | 0 | 68,381 | 43.4 K to 68.4 K (+57.43 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 48,336 | 0 | 132,991 | 84.7 K to 133 K (+57.10 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 724,702 | 0 | 1,993,932 | 1.3 M to 2 M (+57.10 %) |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 1,397,574 | 0 | 1,397,574 | 0 to 1.4 M |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 15,820 | 0 | 15,820 | 0 to 15.8 K |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 42,605 | 0 | 42,605 | 0 to 42.6 K |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 801,619 | 0 | 801,619 | 0 to 801.6 K |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 43,687 | 0 | 43,687 | 0 to 43.7 K |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 84,655 | 0 | 84,655 | 0 to 84.7 K |
| Jul 30 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Buy | C | 0.00 | 1,269,230 | 0 | 1,269,230 | 0 to 1.3 M |
| Jul 24 2020 | ITOS | iTeos Therapeutics ... | GADICKE ANSBERT | Director | Option Exercise | A | 19.00 | 16,608 | 315,552 | 0 |